Почетна › Глиобластом › Florida
Kliničke studije za Глиобластом u državi Florida
30 studija za Глиобластом traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
Zvanični tekst studije (na engleskom)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07326566A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Mayo Clinic in Florida, Jacksonville
- и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05432804A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07464925A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Sylvester Comprehensive Cancer Center*, Miami
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03970447A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Mayo Jacksonville, Jacksonville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT05303467A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- UF Health, Gainesville
Тражи се учесникФаза 1
Узраст 4 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04573140Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07708961Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- и још 6
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06860594Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Jacksonville, Jacksonville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma
- University of Miami, Miami
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07884344SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Florida Health, Gainesville
- Mayo Clinic - Florida, Jacksonville
- University of Miami Health, Miami
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05303519Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Baptist Health Herbert Wertheim Cancer Institute, Miami
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06991101The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07285044Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- UF Health Shands Hospital, Gainesville
Тражи се учесникФаза 2
Узраст од 18 до 90 · Оба пола · Ажурирано 23. 9. 2026. · NCT06558214Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- University of Miami (Data collection only), Miami
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06934889Targeted Pediatric High-Grade Glioma Therapy
- University of Miami, Miami
Тражи се учесникОпсервациона студија
12 Months – 39 Years · Оба пола · Ажурирано 8. 9. 2026. · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- University of Miami Hospital and Clinics, Miami
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 1. 9. 2026. · NCT06161974Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- Baptist MD Anderson Cancer Center, Jacksonville
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06319027Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Florida, Jacksonville
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07091864A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Florida, Jacksonville
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT07074756Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
- University of Miami, Miami
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 29. 7. 2026. · NCT05284643DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- Baptist MD Anderson Cancer Center, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT06805305A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Jacksonville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 4. 2026. · NCT07185880Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 4. 2026. · NCT05789394Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
- Miami Cancer Institute at Baptist Health, Inc., Miami
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 2. 2026. · NCT05756985Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
- Jackson Memorial Hospital, Miami
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 1 до 21 · Оба пола · Ажурирано 8. 12. 2025. · NCT05956821SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.